Sunday, January 18, 2009

Asbestos Fight Outlives the Victim

The UK’s third worst city for asbestos-related deaths is Plymouth. 373 men in Plymouth have died from mesothelioma. The cluster is associated with the use of asbestos on Plymouth docks.

Read More

Saturday, January 17, 2009

Asbestos Fight Outlives the Victim

The UK's third worst city for asbestos-related deaths is Plymouth. 373 men in Plymouth have died from mesothelioma. The cluster is associated with the use of asbestos on Plymouth docks.

Mesothelioma is incurable and is diagnosed in roughly 2000 people yearly. Plymouth is not the only mesothelioma hot spot.

Read More

Wednesday, January 14, 2009

New Mesothelioma Treatments

New Mesothelioma cancer therapies are in the works by Alfacell Corporation, a New Jersey pharmaceutical and research company. Their drug Oncanase apparently has been shown to destroy cancer cells while leaving healthy cells unharmed. Also, the Aldara, a skin cream is testing as a promising cancer fighter in studies using mice. Researchers also are injecting the skin cream directly into a cancer patient’s mesothelioma tumor-the Aldara cream is administered in concert with tumor injected anti-CD40, a stimulant.

Lawsuit Evaluation

Monday, January 5, 2009

British Actor Gets Mistaken Mesothelioma Diagnosis

77-year-old British actor Ken Cope suffered chest pain in October, 2000 and was told at that time that there was a 98% certainty that he had the incurable cancer, mesothelioma.

Read More

Thursday, January 1, 2009

Mesothelioma Survey

There is a mesothelioma survey run by the British Lung Foundation. The British Lung Foundation is the only UK charity working for everyone affected by lung disease. Their resources focus on offering research and support for people affected by lung disease today.

Read More

Thursday, December 18, 2008

A Virus Targeting Mesothelioma?

Farassati, assistant professor with the University’s Medical School and member of the Cancer Center’s Genetic Mechanisms of Cancer Research Program, received a $100,000 grant in 2007 from the Meso Foundation. Read More

Tuesday, December 16, 2008

Mesothelioma Clinical Trial

This study "Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma" is currently recruiting participants.


Read More about the Clinical Trial here at http://news.mesothelioma--lawfirm.com